Literature DB >> 29456189

Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.

Beth A Rousseau1, Zhonggang Hou1, Max J Gramelspacher1, Yan Zhang2.   

Abstract

The microbial CRISPR systems enable adaptive defense against mobile elements and also provide formidable tools for genome engineering. The Cas9 proteins are type II CRISPR-associated, RNA-guided DNA endonucleases that identify double-stranded DNA targets by sequence complementarity and protospacer adjacent motif (PAM) recognition. Here we report that the type II-C CRISPR-Cas9 from Neisseria meningitidis (Nme) is capable of programmable, RNA-guided, site-specific cleavage and recognition of single-stranded RNA targets and that this ribonuclease activity is independent of the PAM sequence. We define the mechanistic feature and specificity constraint for RNA cleavage by NmeCas9 and also show that nuclease null dNmeCas9 binds to RNA target complementary to CRISPR RNA. Finally, we demonstrate that NmeCas9-catalyzed RNA cleavage can be blocked by three families of type II-C anti-CRISPR proteins. These results fundamentally expand the targeting capacities of CRISPR-Cas9 and highlight the potential utility of NmeCas9 as a single platform to target both RNA and DNA.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas9; Neisseria; PAM; RNA cleavage; RNA targeting; RNA-guided; programmable; ribonuclease

Mesh:

Substances:

Year:  2018        PMID: 29456189      PMCID: PMC5889306          DOI: 10.1016/j.molcel.2018.01.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  48 in total

Review 1.  The CRISPR-Cas9 system in Neisseria spp.

Authors:  Yan Zhang
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

2.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

3.  Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.

Authors:  Wenyan Jiang; Poulami Samai; Luciano A Marraffini
Journal:  Cell       Date:  2016-02-04       Impact factor: 41.582

4.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

5.  Programmable RNA Tracking in Live Cells with CRISPR/Cas9.

Authors:  David A Nelles; Mark Y Fang; Mitchell R O'Connell; Jia L Xu; Sebastian J Markmiller; Jennifer A Doudna; Gene W Yeo
Journal:  Cell       Date:  2016-03-17       Impact factor: 41.582

6.  Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.

Authors:  Enbo Ma; Lucas B Harrington; Mitchell R O'Connell; Kaihong Zhou; Jennifer A Doudna
Journal:  Mol Cell       Date:  2015-11-05       Impact factor: 17.970

7.  A Broad-Spectrum Inhibitor of CRISPR-Cas9.

Authors:  Lucas B Harrington; Kevin W Doxzen; Enbo Ma; Jun-Jie Liu; Gavin J Knott; Alireza Edraki; Bianca Garcia; Nadia Amrani; Janice S Chen; Joshua C Cofsky; Philip J Kranzusch; Erik J Sontheimer; Alan R Davidson; Karen L Maxwell; Jennifer A Doudna
Journal:  Cell       Date:  2017-08-24       Impact factor: 41.582

8.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

9.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

10.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

View more
  29 in total

1.  Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Authors:  Max J Gramelspacher; Zhonggang Hou; Yan Zhang
Journal:  Methods       Date:  2019-06-20       Impact factor: 3.608

Review 2.  CRISPR Tools for Systematic Studies of RNA Regulation.

Authors:  Jesse Engreitz; Omar Abudayyeh; Jonathan Gootenberg; Feng Zhang
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 3.  Programmable RNA manipulation in living cells.

Authors:  Yu Pei; Mingxing Lu
Journal:  Cell Mol Life Sci       Date:  2019-07-31       Impact factor: 9.261

Review 4.  CRISPR Tools To Control Gene Expression in Bacteria.

Authors:  Antoine Vigouroux; David Bikard
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-01       Impact factor: 11.056

5.  Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence.

Authors:  Hannah K Ratner; Andrés Escalera-Maurer; Anaïs Le Rhun; Siddharth Jaggavarapu; Jessie E Wozniak; Emily K Crispell; Emmanuelle Charpentier; David S Weiss
Journal:  Mol Cell       Date:  2019-06-27       Impact factor: 17.970

Review 6.  CRISPR-Based Technologies: Impact of RNA-Targeting Systems.

Authors:  Michael P Terns
Journal:  Mol Cell       Date:  2018-11-01       Impact factor: 17.970

Review 7.  Type II anti-CRISPR proteins as a new tool for synthetic biology.

Authors:  Yadan Zhang; Mario Andrea Marchisio
Journal:  RNA Biol       Date:  2020-10-13       Impact factor: 4.652

8.  crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense.

Authors:  Hannah K Ratner; David S Weiss
Journal:  RNA Biol       Date:  2021-03-18       Impact factor: 4.652

Review 9.  CRISPR-Cas guides the future of genetic engineering.

Authors:  Gavin J Knott; Jennifer A Doudna
Journal:  Science       Date:  2018-08-31       Impact factor: 47.728

Review 10.  CRISPR-based functional genomics for neurological disease.

Authors:  Martin Kampmann
Journal:  Nat Rev Neurol       Date:  2020-07-08       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.